MedicarePartD.guide

A non-government resource built from CMS public data

Erzofri on Blue Shield Rx Plus (S2468-003)

paliperidone palmitate

Covered, with prior authorization required.

Tier 4 (non-preferred drug). Quantity limit of 0.25 per 28 days.

$344.11
Patient pays / month, after deductible
$657.76
Patient pays / month, before the $615.00 deductible
$1,032.32
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

ERZOFRI EXTENDED-RELEASE 39 mg/.25mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $702.26 for a month. Other covered strengths are listed below.

Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
FormTierPatient pays / monthLimits
ERZOFRI EXTENDED-RELEASE 117 mg/.75mL Injection5$520.23PA · 0.75 per 28 days
ERZOFRI EXTENDED-RELEASE 156 mg/mL Injection5$650.31PA · 1 per 28 days
ERZOFRI EXTENDED-RELEASE 234 mg/1.5mL Injection5$1,300.58PA · 1.5 per 28 days
ERZOFRI EXTENDED-RELEASE 351 mg/2.25mL Injection5$240.61PA · 4.5 per 365 days
ERZOFRI EXTENDED-RELEASE 39 mg/.25mL Injection4$344.11PA · 0.25 per 28 days
ERZOFRI EXTENDED-RELEASE 78 mg/.5mL Injection5$351.15PA · 0.5 per 28 days

Verify with the plan before prescribing or filling. Member services: (888)239-6469. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s2468-003